Pay by the month or per treatment
FDA Status and What You Need to Know in 2026 Current FDA regulatory status of BPC-157, sermorelin, CJC-1295, and other peptides used in anti-aging medicine
Characterization of proteins by size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS)
If the BMI has dropped below the payer threshold during treatment, continued coverage may require additional documentation showing that discontinuation would likely result in weight regain
Quick answer Epithalon (Epitalon) is an educational research profile for people comparing mechanism, potential benefits, evidence strength, and related compounds in anti-aging & longevity
FDA reviewers cited weak evidence, poor characterization, differences between proposed and studied administration routes, and the availability of approved therapies for the conditions discussed